Cystatin C is associated with adverse COVID-19 outcomes in diverse populations

Sam O Kleeman, Mattia Cordioli, Paul R H J Timmers, Atlas Khan, Pinkus Tober-Lau, Florian Kurth, Vadim Demichev, Hannah V Meyer, James F Wilson, Markus Ralser, Krzysztof Kiryluk, Andrea Ganna, Kenneth Baillie, Tobias Janowitz

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cystatin C is associated with adverse COVID-19 outcomes in diverse populations'. Together they form a unique fingerprint.

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience